current status of electronic brachytherapy...
TRANSCRIPT
October 24, 2014
Current Status of Electronic Brachytherapy Dosimetry
2014 NCCAAPM Fall MeetingLa Crosse, WI
Wes Culberson, PhD, DABRUniversity of Wisconsin – Madison
University of Wisconsin Medical Radiation Research Center (UWMRRC)
October 24, 2014
Current Status of Electronic Brachytherapy Dosimetry
2014 NCCAAPM Fall MeetingLa Crosse, WI
Wes Culberson, PhD, DABRUniversity of Wisconsin – Madison
University of Wisconsin Medical Radiation Research Center (UWMRRC)
Disclosures• UWMRRC receives research support from Xoft, a subsidiary of
iCAD
3 of 43
Outline1. Electronic Brachytherapy Rationale
2. Overview of Commercial Systems
3. Dosimetry Protocols
4. Establishment of NIST-traceable Standards
5. Current Research in the UWMRRC
4 of 43
Uses for a Miniature X-Ray Tubes
• Imaging – x-ray radiography
• Handheld x-ray spectrometers
• Vacuum applications
• Electronic brachytherapy (eBt)
The Amp TeK Mini-X
Image from a 60kVp research x-ray tube based on carbon nanotube field emitters in Korea
5 of 43
Electronic Brachytherapy (EBT) Rationale
• Miniature x-ray sources delivering therapeutic doses of radiation– Brehmsstrahlung x-rays created by targeting electrons onto a high-
Z target (usually gold or tungsten)
• No radionuclides used, thus different regulatory requirements (no radioactive materials license needed)
• Commercial units have energies ranging from 30 – 90kVp
• Adjustable dose rates / tube currents
• Less shielding required due to low energies (compared to 192Ir at least)
• Developed in the late 1980s, ~10 companies have pursued since then
6 of 43
Two Main Applications• Surface (i.e. skin)
• Interstitial, intracavitary, and intraluminary
7 of 43
Carl Zeiss INTRABEAM®Oberkochen, Germany
• 30, 40, and 50kVp at 40 A
• FDA cleared for intracranial, IORT, skin, and partial breast applications (using a balloon applicator)
• Gold target
• 1.2 Gy/min at surface of 1.5cm applicator
Images courtesy of www.zeiss.com 8 of 43
Elekta Nucletron Esteya®Stockholm, Sweden
• 70 kVp x-ray source + flattening filter
• Runs at 0.5 – 1.6 mA
• FDA cleared for surface treatments in 2013
• 3.3 Gy/min at skin surface
Images courtesy of www.elekta.com 9 of 43
Xoft Axxent®Freemont, CA
• Disposable 40kVp or 50kVp source• FDA cleared for PBI, skin, and cervical (anywhere “in or on the body where
radiation is indicated”)• 300 A• 1 Gy/min at 3cm• Originally designed as an alternative to HDR 192Ir
Images courtesy of www.xoftinc.com
10 of 43
XstrahlSurrey, UK
• Not FDA cleared
Photographs of Xstrahl exhibit booth at ASTRO Annual Meeting 2014 11 of 43
Advance X-ray TechnologyBirmingham, MI
• “X-ray Scalpel” – Not FDA cleared
• Microfocus x-ray tube coupled to a capillary optics collimator connected to an insertable tip with a metal target
• Up to 20.2 kVp
• 20Gy/min
Gutman et al., Phys Med Biol 49, 4677-88 (2004)12 of 43
Carbon Nanotube Field Emitters
• Up to 70kVp
• Being developed in Korea
Heo, Kim, Ha, and Cho, “A Vacuum-sealed miniature x-ray tube based on carbon nanotube field emitters”, Nanoscale Research Letters 7: 258, 2012. 13 of 43
Definition of Brachytherapy• Distance?
– Literal Latin translation of brachytherapy is “near” or “short-distance” therapy
– Historically, brachytherapy sources have either been implanted interstitially (inside) or directly on the surface
– eBt units can be implemented interstitially or for surface treatments, but typically are not directly on the surface
– eBt nominal SSDs are ~2.5cm – 6cm
source
Brachytherapy Superficial, SSD 15-25cm
0cm – 6cm SSD
Grenz Ray
Contact Therapy SSD<2cm
14 of 43
AAPM Protocols• None specifically for eBt
• Concepts based on existing reports– TG-43: Brachytherapy dosimetry formalism (1995, 2004)
– TG-56: Code of practice for brachytherapy (1997)
– TG-59: HDR treatment delivery (1998)
– TG-61: Protocol for calibration of kV beams
15 of 43
Dosimetry Protocols• AAPM TG43
– For low-energy LDR and HDR interstitial sources
– Source strength is air-kerma strength, SK
– Uses the average of Monte Carlo calculations and measured values to determine the 3-D dose distributions
– Uses lookup tables or functions to apply these results
16 of 43
Dosimetry Protocols• AAPM TG61 (40-300kVp)
– X-ray tube output standard (measured with a NIST FAC and subsequently transferred by the ADCLs) is air kerma, Kair
– Physicists can use the in-air (<100 kVp) or in-phantom (>100 kVp) measurement method
– Beam quality corrections based on the measured x-ray tube HVL
– Conversion from air-kerma to dose to water achieved by fundamental formulas (mass energy-absorption coefficients, BSFs, etc)
– Uses PDDs to scale the dose
17 of 43
Dosimetry for Surface Applications
• Compatibility of AAPM TG61
• Measuring air kerma, Kair, is possible
• Distances are very close:– effective point of measurement in the chamber needs to be
considered.
– Stem effect normally close to unity since irradiation conditions are similar to calibration conditions.
• For eBt, Monte Carlo based corrections are necessary
18 of 43
Dosimetry for Surface Applications• Modified TG61 protocol
• Fulkerson et al. 2014 equations 3 and 4
R.K.Fulkerson, J.A. Micka, L.A. DeWerd, “Dosimetric characterization and output for conical brachytherapy surface applicators. Part 1. Electronic brachytherapy source”, Medical physics, 2014, Vol.41(2), pp.022103
• Special holders designed
19 of 43
Dosimetry for Interstitial, Intraluminary, and Intracavitary
• Compatibility with TG43
• Air-kerma rate vs air-kerma strength
– SK defined in vacuo• Must correct for attenuation in air
• Calculated Xoft Axxent® spectrum by Dr. Steve Davis 2009
• Difficult to rotate the source
• Energies too high for NIST WAFAC
PMMA holder
20 of 43
Dosimetry for Interstitial, Intraluminary, and Intracavitary
• Dr. Steve Davis measured and calculated the air-kerma strength of an electronic brachytherapy source for his PhD dissertation and determined k=2 uncertainties of 14%– Correcting measurement for filtration in air to account for the entire
spectrum
– Large uncertainties were due to source-to-source variations and uncertainties in the Monte Carlo simulations
• Low energies aren’t clinically relevant, much as in the 4.5 keV Tix-rays around common LDR I-125 and Pd-103 sources
• Filter - air
21 of 43
Establishing NIST-Traceable Standards
• Xoft, Inc. source had a contract with the UWMRRC and subsequently NIST to establish standards for the S700 source
• Initially, went with the AAPM TG43 approach– Sk difficult to measure– Used a hybrid TG43 formalism with AKR @ 1m as the source strength
metric– Conversion to dose is achieved with a conversion coefficient
• Source strength based on air-kerma rate at 1m in air (not in vacuo) measured with the UW Attix FAC
• Conversion to absorbed dose to water based on measurements and Monte Carlo calculations at UWMRRC
• In 2014, NIST introduced a new source strength metric of air-kerma rate in air at 50cm
22 of 43
The NIST Standard for the XOFT Axxent® S700 Source
• Introduced in 2013
• Lamperti Free-Air Chamber (FAC)
• Originally intended to swing the FAC around the source
• Now fixed FAC position
X-ray source
FAC
HPGe spectrometer
Image from NIST.gov
23 of 43
UW Attix FAC• UWMRRC also measured the output with the Attix FAC and
compared with NIST
• Collimation slightly different than Lamperti FAC
• Measured at four cardinal angles
24 of 43
NIST and UW FAC AgreementXoft Axxent® S700 SourcesRound s/n UW FAC
(Gy/s)NIST FAC
(Gy/s) % Diff
1914160 1.890E-04 1.960E-04 -3.6%914219 1.896E-04 1.610E-04 16.3%914230 1.926E-04 1.790E-04 7.3%
2
914552 1.837E-04 1.920E-04 -4.4%924107 1.788E-04 1.860E-04 -3.9%924137 1.824E-04 1.710E-04 6.4%924275 1.923E-04 1.990E-04 -3.4%
3914533 1.712E-04 1.670E-04 2.5%914568 2.017E-04 2.110E-04 -4.5%924201 2.021E-04 1.950E-04 3.6%
• Measurement angles and air attenuation corrections are likely main sources of discrepancy in the first two rounds
25 of 43
Azimuthal Angular Dependence
• FAC results as a function of angle
• Source s/n 914219
Azimuthal Angle Attix FAC Response Relative to Zero Degrees
0 1.00090 1.097
180 1.110270 1.067
Attix FAC
eBt source(top view)
26 of 43
Calibration of Well Chambers• Since clinical users don’t have a FAC, must use well chamber
• Should provide a consistent transfer of AKR to charge readings in the well chamber
– Should give clinically relevant measure of source strength• 4π geometry
• Filter out the low energies (like air and tissue)
27 of 43
The Well Chamber• Standard Imaging HDR 1000 Plus with a specific insert with
~3mm thick Al holder – filters out the lower energies
• Uses a plastic standoff to position the source in the sweet spot (point of maximum response)
• SNR– Great!
– ~100nA ionization current for Xoft Axxent® S700 source (with special insert)
– For reference, well chamber current an LDR seed in its normal insert is ~9 pA and the UW VAFAC is ~50fA
28 of 43
The Well Chamber
29 of 43
Setting up an ADCL Service• Typical well chamber calibration coefficients
– Primary air-kerma measurement performed by NIST on FAC for multiple sources
– Sources sent to a ADCL and measured in a well chamber.
– Ratios of air-kerma to well chamber current used as calibration coefficient
– Hoping for tight range of coefficients
– Coefficients will vary slightly for LDR sources (+/- 2%) due to internal construction of sources
30 of 43
Source-to-Source Variations
• Not all tungsten targets made the same, especially for these sizes
• Effects of spectral differences– Will affect conversion from AKR to dose to water
– Low energy component of spectrum will be the main issue
31 of 43
Initial UWADCL Well Chamber ResultsXoft Axxent® Sources
Average of Round 3
values used as the final cal
coefficient
32 of 43
Implementation of a New Standard
• UWADCL calibrations for the XOFT Axxent® Model S700 source approved by AAPM CLA in summer, 2014
• Slight modification of TG43 is needed to accommodate the new source strength metric of AKR at 50cm in air
• Manuscript submitted by DeWerd et al. to Medical Physics Journal– Proposes a formalism to use the new NIST standard
– Proposes the Dose Conversion Coefficient, χ
– Proposes applicator specific values (not in TG43)
33 of 43
Current Research in the UWMRRC
• Measurement of dose surrounding eBt sources
• Applicators and their effect on eBt dosimetry
• Relative biological effectiveness (RBE)
34 of 43
Measuring Dose Around an eBt Source
35Photograph courtesy of Sam Simiele 35 of 43
Applicators• Common for brachytherapy intracavitary treatments
• For 192Ir, metal applicators disrupt the dose distribution minimally
• Electronic brachytherapy will attenuate by a factor of 8!
• All lookup values should be applicator specific
36 of 43
Applicators
37 of 43
Measured vs Calculated Results
• Active area of research at UWMRRC by Sam Simiele
• Both bare and in applicator results show substantial disagreement between measured and predicted dose distributions– Difficult to identify the source of the discrepancy
– Monte Carlo?
– TLD energy dependence?
38 of 43
RBE• RBE of eBt is under scrutiny
• Lower energy, longer treatment times (~10-15 min for IORT)
192Ir Xoft Axxent®
39 of 43
RBE• Recall, RBE depends on LET
• LET of 10keV x-rays is 10x higher than 1MeV x-rays
• RBE decreases with depth due to beam hardening– Estimated to vary by a factor of 1.5 by Brenner et al. 1999
40 of 43
Conclusions• Recent years have seen a surge of new eBt manufacturers
• Current AAPM dosimetry protocols need revisions before being implemented for eBt
• NIST-traceable air-kerma standards have been established for the Xoft Axxent® Model S700 source
• Research is underway in the UWMRRC to solve some of the remaining challenges
41 of 43
Acknowledgements• UWMRRC students and staff
• UWADCL customers for their continued support
42 of 43
Questions
43 of 43